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A B S T R A C T
Imbalances in glutamatergic (excitatory) and GABA (inhibitory) signalling within key brain networks are
thought to underlie many brain and mental health disorders, and for this reason there is considerable interest in
investigating how individual variability in localised concentrations of these molecules relate to brain disorders.
Magnetic resonance spectroscopy (MRS) provides a reliable means of measuring, in vivo, concentrations of
neurometabolites such as GABA, glutamate and glutamine that can be correlated with brain function and
dysfunction. However, an issue of much debate is whether the GABA observed and measured using MRS
represents the entire pool of GABA available for measurement (i.e., metabolic, intracellular, and extracellular)
or is instead limited to only some portion of it. GABA function can also be investigated indirectly in humans
through the use of non-invasive transcranial magnetic stimulation (TMS) techniques that can be used to
measure cortical excitability and GABA-mediated physiological inhibition. To investigate this issue further we
collected in a single session both types of measurement, i.e., TMS measures of cortical excitability and
physiological inhibition and ultra-high-ﬁeld (7 T) MRS measures of GABA, glutamate and glutamine, from the
left sensorimotor cortex of the same group of right-handed individuals. We found that TMS and MRS measures
were largely uncorrelated with one another, save for the plateau of the TMS IO curve that was negatively
correlated with MRS-Glutamate (Glu) and intra-cortical facilitation (10ms ISI) that was positively associated
with MRS-Glutamate concentration. These ﬁndings are consistent with the view that the GABA concentrations
measured using the MRS largely represent pools of GABA that are linked to tonic rather than phasic inhibition
and thus contribute to the inhibitory tone of a brain area rather than GABAergic synaptic transmission.
Introduction
GABA is the main inhibitory neurotransmitter in the brain. It is
present in 25–50% of synapses and has a critical role in regulating
excitability throughout the brain. Dysfunction in GABA signalling is
also core to many common neurological and psychiatric conditions:
including neurodevelopmental disorders such as autism and Tourette
syndrome (Clarke et al., 2012; Ramamoorthi and Lin, 2011).
Consistent with this view, post-mortem investigations of Tourette
syndrome (TS) have demonstrated that there are substantial decreases
(~50%) in the number of GABA interneurons within the striatum
(Kalanithi et al., 2005), and positron emission tomography (PET)
imaging studies have reported widespread alterations in GABAA
receptor binding throughout the brain in TS, including in particular
the striatum, thalamus and insula cortex (Lerner et al., 2012). Most
importantly, with respect to the focus of the current study, transcranial
magnetic stimulation (TMS) studies of physiological inhibition have
repeatedly demonstrated reduced short interval intra-cortical inhibi-
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tion (SICI) in TS (Gilbert et al., 2004; Heise et al., 2010; Orth et al.,
2008). As SICI is thought to be predominantly dependent on GABA-A
receptor activity (see Ziemann (2013) for a review) these ﬁndings have
suggested a role of dysfunctional GABAergic signalling in TS.
Non-invasive in-vivo investigation of localised concentrations of
GABA within the brain is possible using proton magnetic resonance
spectroscopy (MRS). Detection of some neurometabolites, such 1H
MRS can be challenging due to low concentration and signal overlap
with more concentrated metabolites. Ultra-high ﬁeld oﬀers the advan-
tages of increased spectral resolution and signal-to-noise ratio (SNR)
compared to lower ﬁeld strengths (Choi et al., 2010; Stephenson et al.,
2011; Tkáč et al., 2001; Tkáč et al., 2009). In the context of the current
study it is of interest to note that MRS studies of GABA concentration
within the cortical motor areas in TS have reported either no
diﬀerences in GABA concentration (Draper et al., 2014; Puts et al.,
2015; Tinaz et al., 2014) or increased levels of GABA relative to age-
matched controls (Draper et al., 2014).
The ﬁndings outlined above in relation to TS illustrate an apparent
contradiction. Speciﬁcally, while numerous TMS studies have reported
that GABA-A mediated physiological inhibition (SICI) is substantially
reduced in TS (Gilbert et al., 2005; Orth et al., 2005; Ziemann et al.,
1997) recent MRS studies has reported either no diﬀerences in GABA
concentration, or increased GABA concentrations within the SMA
(Draper et al., 2014) that are associated with decreased gain in motor
cortical excitability Draper et al., 2014), a ﬁnding that has been widely
reported in TS (Draper and Jackson, 2015; Heise et al., 2010).
However, it is important to note that these apparently contradictory
results are only problematic if we assume that TMS measurements of
GABA-mediated inhibition and MRS measurements of localised GABA
concentrations are indexing the same inhibitory function.
It is widely accepted that TMS measures of GABA-mediated
physiological inhibition such as SICI are likely to be indexing the
operation of low threshold, transiently activated, cortical GABA inter-
neurons (Ziemann et al., 1996; Ziemann et al., 1996). In particular,
pharmacological studies suggest that SICI measured using inter
stimulus intervals (ISI) of 1.5-5ms are largely dependent on GABA-A
receptor activity (Hanajima and Ugawa, 2008, Ziemann, 2013, 2015).
By contrast, it has been argued that the GABA observed and measured
using MRS largely represents extracellular concentrations of GABA
that are linked to the ‘tonic’, GABA-ergic, inhibitory tone of a localised
brain region (Rae, 2014; Stagg, 2014). If this is indeed the case, then it
would be unsurprising that both decreased transient ‘phasic’ inhibition
and increased ‘tonic’ inhibition could be observed within a particular
patient group, particularly if the latter can be viewed as the conse-
quence of an adaptive, compensatory, response to the former, as has
been argued by several authors (Draper et al., 2014; Heise et al., 2010).
Two recent studies sought to address this issue directly by
investigating the relationship between TMS measures of SICI and
MRS measures of GABA within the primary sensorimotor cortex [PMC]
(Stagg et al., 2011; Tremblay et al., 2013) collected from the same
individuals. Both studies acquired MRS data at conventional MR ﬁeld
strengths (3 T), and one study investigated GABA concentrations using
a GABA-edited (MEGA-PRESS) sequence (Tremblay et al., 2013). The
results of these studies are inconclusive. Stagg et al. (2011) reported
that MRS-GABA concentrations within the PMC were uncorrelated
with 2.5ms SICI measurements, but were signiﬁcantly correlated with
the slope of the 1ms SICI curve. The physiological mechanisms
underlying 1ms SICI eﬀects are thought to be distinct from those
occurring at later ISIs and although these mechanisms are not yet fully
understood, it has been suggested that the eﬀects may reﬂect axonal
refractory periods (Fisher et al., 2002). Stagg et al. (2011) suggest that
MRS measures extra-synaptic, tonic inhibition and that GABA that may
be associated with the duration of the refractory periods of neuronal
axons.
Tremblay et al. (2013) also reported that MRS-GABA concentra-
tions within the PMC were uncorrelated with any TMS measurements,
including 3ms SICI, but these authors did not measure 1ms SICI, so we
cannot know if the 1ms SICI eﬀect observed by Stagg et al. (2011) is
replicable.
The Stagg and Tremblay studies also diﬀer in the associations that
they reported for other TMS/MRS metabolite pairings, partially due to
the use of diﬀerent TMS measurements. Thus, while Stagg et al. (2011)
reported that a general measure of cortical excitability, the slope of the
TMS recruitment (IO) curve, was signiﬁcantly associated with MRS
glutamate concentrations within the PMC, Tremblay et al. (2013)
reported a signiﬁcant positive correlation between Glx (a composite
measure of glutamate and glutamine) and the duration of the cortical
silent period (CSP).
Furthermore, in addition to diﬀering on which particular TMS
measures to relate to MRS measures of motor cortical excitability and
physiological inhibition, the above studies also diﬀered in that one
study used a GABA-edited MRS sequence (Tremblay et al., 2013) while
the other (Stagg et al., 2011) did not. This may have had important
implications for the measurements obtained, particularly as both
studies were conducted at conventional MR ﬁeld strengths.
The advantages of ultra-high ﬁeld (7 T) are the increased signal-to-
noise ratio (SNR) obtained and greater chemical shift dispersion (Tkáč
et al., 2009). The increased SNR improves the detection sensitivity and
eﬃciency of metabolites, especially those with low concentration such
as GABA. Greater chemical shift dispersion increases the separation of
signals with similar resonance frequencies, allowing a more accurate
identiﬁcation and quantiﬁcation of each metabolite. For instance, due
to spectral overlapping the diﬀerentiation of GABA, Glu and Gln signals
are diﬃcult in 1H spectra at ﬁeld strengths of 3 T or less (Puts and
Edden, 2012), and Glx (a composite measure of Glu + Gln) is reported
instead. By contrast, GABA, Glu and Gln become separable at ﬁeld
strengths of 7 T or above. Also, GABA-edited (J-diﬀerence editing)
sequences (Mescher et al., 1998; Near et al., 2013) rely on subtraction
to remove overlapping signals from the spectrum. This technique is
therefore particularly susceptible to motion-related errors that are less
of an issue for non-edited MRS sequences (e.g., STEAM) that can be
utilised at 7 T (Bhattacharyya et al., 2007; Bogner et al., 2014).
In the current study, we investigated this question by directly
comparing a wide range of TMS measurements of motor cortical
excitability (including TMS recruitment curves and paired-pulse mea-
sures of intra-cortical facilitation [ICF]) and physiological inhibition
(including both 1ms and 3ms SICI) with MRS measures of GABA, Glu
and Gln acquired at ultra-high-ﬁeld (7 T) using a non-edited STEAM
sequence.
Subjects
29 healthy right handed adults (age range 19–27) participated in
the study. All participants were free from neurological or psychiatric
illness and any contraindications for MR scanning or TMS. Of the 29
participants recruited, two were subsequently excluded from the
analysis: one due to poor quality TMS data and one due to poor quality
MRS data (details below). Details of the 27 participants included in the
data analyses are contained in Table 1.
MR acquisition
All MR data were acquired using an ultra-high ﬁeld 7 T Philips
Table 1
Participant demographics. Data are presented as mean value ± sd. RMT = mean resting
motor threshold. SI 1 mV = mean stimulator output required to produce a MEP with an
amplitude of 1 mV. † Percentage of maximal stimulator intensity.
N Sex (M/F) Age rMT † S1 1MV †
27 13/14 23.1 ± 2.4 45.7 ± 6 55.3 ± 6.8
K. Dyke et al. NeuroImage 152 (2017) 360–370
361
Achieva system (Philips Healthcare, Best, Netherlands) with a 32-
channel radio frequency head coil at the Sir Peter Mansﬁeld Imaging
Centre (SPMIC), University of Nottingham. Participants were placed
supine and head-ﬁrst into the scanner. Foam pads were inserted
between the participant's head and the coil to minimise and control
head movement; a pair of prism glasses were provided to allow
participants to view a screen outside the magnet bore.
At the start of each imaging session 1H image localiser and B0 maps
were acquired, followed by BOLD-fMRI T2
*-weighted images, which
were acquired to guide placement of the left primary motor cortex
(PMC) spectroscopy voxel in the following MRS scans. The BOLD-fMRI
used a single shot EPI sequence (TR/TE=1999/25 ms, FOV=208×192
mm3, matrix=112×112, 30 slices, slice thickness=4mm, no slice gap,
160 dynamics). During the fMRI scan, eight blocks of bimanual ﬁnger-
to-thumb opposition tapping were performed in a blocked-trial para-
digm as follows. The words ‘TAP’ and ‘REST’ were alternately displayed
for 8 s and 32 s, respectively. Participants were asked to tap their
thumbs to each ﬁnger with both hands simultaneously and continu-
ously during the ‘TAP’ phase and to rest (withhold movement) during
the ‘REST’ phase. Maximum activation of the left M1 was found by
analysing the BOLD response on-line using the Philips IViewBOLD
software.
T1-weighted anatomical images were then acquired with a
MPRAGE sequence (TR/TE/TI=7.3/3.4/998 ms, FA=8o,
FOV=224×224×120 mm3, isotropic resolution=1mm3) for tissue seg-
mentation. Anatomical landmarks from these images were also used to
assist in the placement of the left PMC voxel for MRS.
In vivo 1H MRS data were acquired from a voxel of interest
(VOI=20×20×20mm3) placed over the hand area in the left M1
(Fig. 1[A]) using a STEAM sequence (TE/TM/TR=17/17/2000ms,
sample size=4096, spectral bandwidth=4000 Hz, phase cycling=8,
288 averages, 9.6 min). Water suppression was performed using
multiply optimised insensitive suppression train (MOIST) (Murdoch,
1993). Prior to this, a non-suppressed water reference spectrum (16
averages) from the same VOI was acquired for eddy current correction
and quantiﬁcation. B0 shimming of the VOI was performed automa-
tically by the Philips pencil beam (PB) algorithm (Gruetter, 1993) in
order to increase B0 ﬁeld homogeneity.
Test – retest reliability and reproducibility of MRS
measurements
To determine the reliability and consistency of our MRS measure-
ments we examined the test-retest reliability of our MRS data.
Speciﬁcally, an additional dataset was obtained from a sub-set of 12
participants who were selected randomly from the sample described
above. This second MRS dataset was collected on the same day,
approximately 3 h after, the initial MRS dataset was collected. It
should be noted that both datasets were collected in an identical
manner, and followed the identical procedure as outlined above.
Intra-class correlation coeﬃcient (ICC (2,1)) analyses were used to
explore the reliability of key MRS measures (i.e., GABA/tCr, Glu/tCr,
Gln/tCr,) across the two sessions. ICC results are reported based upon
Lahey et al. (1983), whereby ICC values of < 0.4 are considered to
indicate poor intra-class reliability, values > 0.4 and < 0.59 indicate
fair intra-class reliability, values > 0.6 and < 0.74 indicate good intra-
class reliability, and values > 0.74 indicate excellent intra-class relia-
bility. Negative ICC values are taken to indicate a lack of reliability
within the measure.
The ICC(2,1) analysis of GABA/tCr yielded an intra-class correla-
tion coeﬃcient of 0.62 which indicates good intra-class reliability. The
ICC(2,1) analysis of Glu/tCr yielded an intra-class correlation coeﬃ-
cient of 0.61 which also indicates good intra-class reliability. The
ICC(2,1) analysis of Gln/tCr yielded an intra-class correlation coeﬃ-
cient of 0.44 which indicates fair intra-class reliability.
A previous study by Wijtenburg and colleagues (Wijtenburg et al.,
2013) reported on the reproducibility of MRS GABA measurements
and found that MRS GABA concentrations varied across brain regions.
Speciﬁcally, they reported reproducibility (indexed by the coeﬃcient of
variation [CV]) was diﬀerent in the anterior cingulate cortex (CV =
3.2%) and the dorsolateral prefrontal cortex (CV = 16.2%). As this
study did not investigate the reproducibility of GABA within the
primary motor cortex we report these measurements here. We calcu-
lated the CV for each individual across the two testing sessions as
outlined above. The mean and median values for the group were as
follows: GABA mean CV = 11.91% (median = 5.56%); Glu mean CV =
3.52% (median = 3.46%); Gln mean CV = 18.05% (median = 12.66%).
Fig. 1. [A] Represents the overlap of the voxel of interest (VOI=20x20×20 mm3) over the left hand area of M1 shown in (i) sagittal, (ii) axial (iii) and coronal views. The colour bar
represents the percentage MRS voxel overlap across 27 subjects (from 10–100%). The voxel positions from each subject were transformed into a standard brain space (as shown in the
Figure) to calculate the percentage of voxel overlap. [B] Standard deviations (shaded area) overlying the group mean in vivo spectrum acquired from the VOI obtained with the STEAM
sequence (TE/M=17/17 ms) at 7Tare shown. [C] A representative in vivo spectrum obtained from the M1 VOI is shown, together with its LCModel ﬁt. Residual, and ﬁtted signals for
metabolites of interest and macromolecules (MM), baseline (BL) are also shown.
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These data conﬁrm that GABA reproducibility in the primary motor
cortex are comparable to the data reported for other brain areas by
Wijtenburg et al. (2013).
TMS measurements and EMG recording
MR scanning sessions were performed before TMS measurements
were obtained. On average the time in between the ﬁnal MR scan and
the commencement of the collection of TMS measurements was
30 min.
TMS was delivered using a Magstim Bistim system (Magstim,
Whiteland, Dyfed, UK) with a ﬁgure-of-eight magnetic coil (70mm
diameter of each winding). The coil was held tangentially to the scalp
and positioned 45° from the midline, resulting in a posterior to anterior
current ﬂow. Neuronavigation software (Brain site, Rogue research
Inc., Montreal Quebec, Canada) was used in conjunction with indivi-
dual T1-weighted anatomical images (acquired using the MPRAGE
sequence outlined above) to aid coil placement over the hand area of
the left primary motor cortex. All TMS measures were obtained from
the motor hot spot identiﬁed for the First Dorsal Interosseous (FDI)
muscle. This was deﬁned as the location that consistently yielded the
largest MEP amplitudes for the FDI. Participants were required to
remain still during testing, and head movements were minimised with
the aid of a chin rest. Participants were oﬀered frequent breaks to
stretch and adjust their position and neuronavigation was used to
accurately reposition the coil over the motor hot spot on each occasion.
The coil was held stable over the hot spot using a Manfrotto mechanical
arm (Vitec Group, Italy) and adjusted when necessary.
Motor evoked potentials (MEPs) were recorded using disposable
Ag-AgCl surface electrodes attached to the right FDI muscle in a belly-
tendon montage. The signals were ampliﬁed and bandpass ﬁltered (10
Hz–2 kHz, sampling rate 5 kHz) then digitalized using Brainamp ExG
(Brain Products GmbH, Gilching, Germany) controlled by Brain Vision
Recorder (Brain Products GmbH, Gilching, Germany). Participants
were encouraged to maintain their hand in a relaxed position through-
out testing.
All trials were controlled using an in-house program (written using
Matlab: Mathworks, MA, USA), with an inter-trial interval of 5 s
occurring between each trial for all measures. Intra-cortical inhibition
and facilitation were investigated using a range of TMS paired pulse
protocols, with a range of inter-stimulus intervals (ISIs) including 1, 3,
10 and 12 ms (Kujirai et al., 1993). A 100 ms ISI inhibitory protocol
was also measured (Claus et al., 1992; Valls-Sole et al., 1992). All
paired pulse measures and unconditioned trials were randomized and
presented within the same session. Input output curves were always
calculated prior to paired pulse measures.
Threshold determination
Resting motor threshold (RMT) was determined as the lowest
intensity needed to yield an MEP with a peak-to-peak amplitude of
> 50 µV in the relaxed FDI muscle in a minimum of 5 of 10 trials. A
1 mV (SI 1 mV) threshold was also determined by calculating the
lowest intensity needed to evoke an MEP of 1 mV in 5 of 10 consecutive
trials.
Input output curves
TMS intensities at 100, 110, 120, 130, 140 and 150% of RMT were
used. 10 pulses at each of the 6 intensities were delivered in a
randomized order.
Unconditioned trials
A total of 30 unconditioned trials were measured at SI 1 mV
(Fig. 2A).
Short interval intracortical inhibition (SICI)
SICI was measured using 1 and 3 ms ISIs. The selection of
conditioning stimuli (CS) intensities was informed by a pilot study
(data not shown) which revealed 1 ms SICI to have a lower threshold
than that of 3ms SICI. This ﬁnding conﬁrms previous research (Fisher
et al., 2002) and therefore CS intensities of 45%, 50%, 55% and 60%
RMT were used to measure 1ms SICI, whereas 60%, 65%, 70% and
75% RMT were used to measure 3ms SICI. Each CS was followed by a
suprathreshold test stimulus (TS) of SI 1 mV delivered to the same
location (Fig. 2B). Ten trials were measured for each CS-TS pairing for
both 1 and 3 ms ISIs.
Long interval intra-cortical inhibition (LICI)
A single ISI of 100 ms was tested using a suprathreshold CS of
110% RMT and a TS delivered at SI 1 mV. A total of 20 trials were
measured.
Intracortical facilitation (ICF)
10 and 12 ms ISIs were measured using a CS at 75% RMT followed
by a SI 1 mV TS (Fig. 2C). 20 trials were measured for each ISI.
Fig. 2. Illustrates representative MEPs. [A] shows an MEP from an unconditioned trial
following the delivery of a single TMS test stimulus (SI 1 mv); [B] shows an MEP for a
paired-pulse SICI trial. In this case the same test stimulus that is preceded (3 ms) by a
sub-threshold CS; and, [C] shows an MEP for a paired-pulse ICF trial. In this case the test
stimulus is preceded (10 ms) by a sub-threshold CS.
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Results
Analyses of MRS data
In vivo 1H spectra were ﬁtted and quantiﬁed with the LCModel
software package (Provencher, 1993). The basis set used for quantiﬁ-
cation included an experimentally acquired macromolecule spectrum
and model spectra of 20 metabolites. The LCModel analysis was
performed within the chemical shift range 0.5 to 4.2 ppm. Water
scaling was applied using the non-suppressed water reference. The
LCmodel control parameters were based on previously published
parameters (Tkáč et al., 2009). The absolute concentration for each
cerebral metabolite is reported in institutional units. Metabolites with
Cramer-Rao lower bound (CRLB) > 30% were rejected from further
analysis. Mean ± SD CRLB for Glu was 2% ± 0%, for Gln this was
6.98% ± 2.76% and for GABA this was 9.9% ± 4.6%. The line width of
in vivo spectra were 10.35 ± 1.99 Hz. Total Cr (tCr, i.e., PCr+Cr) was
used as the internal reference for quantiﬁcation due to its relatively
high and stable concentration in the human brain (Danielsen and Ross,
1999; Stagg and Rothman, 2014).The group mean in vivo spectrum
acquired from the VOI is presented in Fig. 1[B]. Any signiﬁcant outliers
were identiﬁed and removed using Grubbs test.
Analyses of TMS data
All trials were carefully inspected visually and trials in which there
was evidence of pre-contraction of the FDI muscle in the period 500ms
prior to an MEP were excluded. For the remaining data, peak-to-peak
MEP amplitudes were measured using in house software (programmed
using Matlab, Mathworks, MA, USA). When analysing individual
participant data, median values were calculated to indicate average
MEP amplitude in response to a particular stimulator output. The
mean of median values was calculated across the participants for each
dependent variable. Any signiﬁcant outliers in group mean values were
identiﬁed and removed prior to analyses using Grubbs test.
Resting motor thresholds (RMT)
The group mean RMT was 45.7 ( ± 6) of maximum stimulator
output. The group mean for the 1mV (SI mV) threshold (i.e., the lowest
intensity needed to evoke an MEP of 1mV in 5 of 10 consecutive trials)
was 55.3( ± 6.8) %. The group mean MEP amplitude for a TMS pulse
delivered at SI 1mV was 1365.3 ( ± 556.9)mV.
TMS recruitment (IO) curves
Single pulse TMS IO curves were measured by calculating for each
individual the median MEP amplitude for each given TMS intensity
(100−150% RMT). Four-parameter sigmoidal ﬁts were then applied to
the resultant values and the maximal slope and the plateau of the curve
were calculated. The sigmoidal function used to ﬁt curves to the
individual datasets was:
yMEP = + MEP
1+10S S S k0
MAX
( − )50
MEPMAX is the maximumMEP amplitude measured, S50 is the TMS
intensity needed to produce 50% of the maximum MEP, k is the
gradient of the maximum steepness of the curve and y0 is the minimal
MEP response, which was set to 0.
Group IO curve data are presented in Fig. 3. Inspection of this
ﬁgure clearly illustrates that in our study, increased TMS stimulator
intensity led to increased MEP amplitudes. This was conﬁrmed by
statistical analysis using a one way ANOVA which yielded a signiﬁcant
eﬀect of stimulator intensity (F[5,156] = 26.08, p < 0.0001). Two
measures of interest were taken from the sigmoid curve: the maximum
slope of the sigmoid (IO curve slope) and plateau of the sigmoid (IO
plateau).
Paired pulse data
Paired pulse trials were analysed by calculating for each individual
the median MEP amplitude for each CS intensity at each ISI. These
values were then divided by the median MEP amplitude for uncondi-
tioned trials to create a ratio measure. Linear slopes were ﬁtted to 1ms
and 3ms SICI measures (Fig. 4) and a median value was calculated
across the diﬀerent CS intensities to reveal the average level of
inhibition. Individual median MEP values were also calculated for
ICF trials, the resultant group data are presented in Fig. 4. Inspection
of this ﬁgure clearly illustrates that while the SICI paired pulse trials
(ISIs 1 ms and 3 ms) led to a large reduction of the MEP produced by
the test stimulus, the ICF trials (ISIs 10 ms and 12 ms) led to a large
increase in the MEP to the test stimulus. These data are consistent with
the inhibitory and excitatory eﬀects of SICI and ICF paired pulse TMS
stimulation. Statistical analysis using a one way ANOVA conﬁrmed that
there was a signiﬁcant eﬀect of stimulator intensity on MEP amplitudes
for both the 1 ms SICI curve (F(3,104)=32.58, p < 0.0001) and the
3 ms SICI curve (F(3,107) = 19.23, p < 0.0001). Paired sample t-tests
Fig. 3. Group mean of individual median MEPs following stimulation of 100–150% of
individual RMT. The errors bars are SEM and the shaded region is the 95% conﬁdence
intervals of the sigmoidal function ﬁtted to the data.
Fig. 4. Group mean of individual median MEP values for paired pulse SICI (1 ms and
3 ms ISI) and ICF (10 ms and 12 ms ISI) trials. Error bars represent the standard error of
the mean.
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conﬁrmed that the values for both 10 ms ICF trials (t(26)=10.8,
p=.000) and 12 ms ICF (t(26)=10.63, p=.0001) diﬀered signiﬁcantly
from unconditioned trials.
Following initial analyses, it was determined that data from LICI
trials would not be analysed further. This was based upon the large
percentage of participants who exhibited ﬂoor levels for this measure
(i.e., there was a complete inhibition of the MEP in 8/27 participants).
While this illustrates that the LICI paired pulse TMS procedure was
highly eﬀective, it reduces individual variability in LICI values and
therefore makes the correlation analyses less eﬀective.
Correlations between MRS and TMS measures
The key focus of this study was to directly examine the association
between TMS measures of physiological inhibition - assessed by TMS
stimulation of the hand area of the primary motor cortex (PMC) of the
left hemisphere - with MRS measurement of GABA concentration –
acquired from a voxel centred over the hand area of the PMC of the left
hemisphere. To examine this association Pearson correlation coeﬃ-
cients were calculated for the entire set of TMS measures against a
measure of PMC GABA concentration. For completeness correlations
are reported without adjustment for multiple comparisons. Where
correlation coeﬃcients are statistically signiﬁcant we report the ad-
justed statistical threshold (alpha) calculated for multiple comparisons
using the Holm-Bonferroni correction method for each neurotransmit-
ter separately.
The TMS measures used in the analyses consisted of the following
ten measurements for each individual: the resting motor threshold
(RMT 50–100 μV); the median MEP for a single, unconditioned,
TMS stimulus delivered at that individual's RMT (med MEP); the
stimulator output (%) required to produce an MEP of approximately
1 mV (SI 1 mV); the linear slope of the TMS IO curve (IO curve); the
median inhibition value (%) observed for 1ms SICI trials (1 ms SICI);
the linear slope value for 1 ms SICI trials (1 ms SICI slope); the
median inhibition value (%) observed for 3 ms SICI trials (3 ms SICI);
the linear slope value for 3 ms SICI trials (3 ms SICI slope); the
median value (%) observed for 10ms ICF trials (10 ms ICF); and, the
median value (%) observed for 12ms ICF trials (12 ms ICF).
We used the ratio of GABA to total Creatine (tCr) as our measure of
GABA concentration. For completeness, and to maintain comparability
with previous studies including our own, we also investigated the ratio
of GABA to N-acetylaspartate (NAA). These analyses yielded similar
results to the tCr ratio data and in the interests of brevity are not
reported here. In addition, while the primary focus of this study was to
examine the association between TMS measures of physiological
inhibition (e.g., SICI) and MRS measures of GABA (hereafter referred
to as MRS-GABA), for completeness we report the relationship of our
TMS measures with MRS measures of Glutamate (Glu), Glutamine
(Gln), and the ratio of Glutamine to Glutamate.
Association of TMS measures with GABA
GABA/tCr
Fig. 5 displays a spider plot of the Pearson correlation coeﬃcients of
the TMS measures with GABA/tCr ratio. These analyses revealed that
all eﬀects failed to reach conventional levels of statistical signiﬁcance
(all p > 0.29). In particular, the correlation coeﬃcients for 1 ms and
3 ms SICI did not approach statistical signiﬁcance for either median
inhibition (1ms SICI: r = −0.19, p=0.34; 3 ms SICI: r = −0.08, p=0.68),
or slope (1 ms SICI: r = −0.17, p = 0.39; 3 ms SICI: r = 0.06, p = 0.77).
Association of TMS measures with glutamate
Glu/tCr
Fig. 6 displays a spider's web plot of the Pearson correlation
coeﬃcients of the TMS measures with Glu/tCr ratio. There was a
signiﬁcant negative relationship between IO plateau and Glu/tCr
(r=−0.74, p < 0.0001 [corrected using Holm-Bonferroni method]) but
not for IO maximal slope (r=−0.197, p=0.34) or RMT (r=−0.09,
p=0.67). A signiﬁcant positive relationship was found between Glu/
tCR and 10 ms ICF (ICF 10 ms: r=0.52, p < 0.01), however this did not
survive Holm-Bonferroni correction (r=0.52, p=0.08). 12 ms ICF was
not found to have any relationship to Glu/tCR (ICF 12 ms: r=0.06,
p=0.78).
Fig. 5. Spider's web plots illustrate Pearson correlation coeﬃcients for individual values
for each TMS measurement relative to speciﬁc MRS measures (metabolite ratios). This
ﬁgure illustrates Pearson correlation coeﬃcients for TMS measures with GABA/tCr
ratios. The plot presents correlation coeﬃcients running from 1.0 (outer ring) to −1.0
(inner ring), with the broken black line representing a correlation coeﬃcient of zero. The
grey region represents non-signiﬁcant correlation coeﬃcient values. The broken blue line
represents the observed correlation coeﬃcients for each TMS measure. Open blue circles
are not statistically signiﬁcant (p > = 0.05) and ﬁlled blue circles represent statistically
signiﬁcant correlations (p < 0.05). The analyses revealed that there were no statistically
signiﬁcant correlations between GABA concentration and any TMS measure.
Fig. 6. Spider web plots that illustrate Pearson correlation coeﬃcients between
individual values for each TMS measurement and Glutamate concentrations (Glu/tCr
ratios). The analyses revealed that there was a signiﬁcant positive correlation between
glutamate concentration and 10 ms ICF and a negative correlation with the plateau of
TMS IO curves.
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Association of TMS measures with glutamine
Gln/tCr
Fig. 7 displays a spider's web plot of the Pearson correlation
coeﬃcients of the TMS measures with Gln/tCr ratio. The analysis
revealed a signiﬁcant correlation between the Gln/tCr ratio and the
median amplitude of MEPs in response to stimulation at RMT
(r=−0.40, p=0.05), although this did not survive the Holm-
Bonferroni correction (r=−0.4, p=0.5). Neither RMT (r=0.11,
p=0.61) nor IO maximal slope (r=−0.01, p=0.97) were signiﬁcantly
associated with Gln/tCR concentration and all other correlations failed
to reach statistical signiﬁcance. Fig. 8.
Multiple regression analyses
To address any potential multivariate eﬀects, we entered the
following six MRS measures as separate predictors into a multiple
regression model: GABA/tCR; Glu/tCR; Gln/tCR; GABA/Glu; GABA/
Gln; and Gln/Glu. These predictors were then used to predict each of
the TMS measurements in turn.
These analyses conﬁrmed that the magnitude of the median MEP
obtained at RMT was predicted by a combination of the Gln/Glu ratio
(t=−3.428, p=0.03) and GABA/Glu ratio (t=−2.848, p=0.01)(t = −3.09,
p = 0.005); R2 = 0.4, F = 7.09566, p = 0.004.
The model also revealed that 10ms ICF was predicted by Glu/tCR
ratio (t=−2.915, p=0.008), R2= 0.270, F=8.495, p=0.008. In addition
to this Glu/tCR was found to signiﬁcantly predict IO plateau (t=−2.915,
p=.008), R2= 0.270, F=8.495, p=0.008.
Bayesian statistics
To overcome potential limitations of conventional correlational
analyses, a Bayesian Hypothesis test was conducted. This was used
primarily to evaluate whether there was evidence in favour of the null
hypothesis (H0), i.e. that a metabolite bore no relationship with
neurotransmitter function as assessed by TMS. It further allowed us
to quantify the strength of the relationship of any correlations found
(evidence in support of the alternative hypothesis, H1). Bayes Factors
(BF10) were calculated using JASP (JASP-Team, 2016), JASP uses the
Bayesian correlation test proposed by Jeﬀreys (1961). Bayes Factors
above 1 show support for H1 whilst below 1 show support for the H0,
the magnitude of the BF10 shows the strength of the evidence in
support of either the H1 or H0. For cut-oﬀ values for the diﬀerent
strengths of evidence please see Table 2.
In support of previous analysis, the Bayesian Hypothesis test
showed there was decisive evidence that Glu/tCr is related to IO
plateau (BF10=1119.593) and substantial evidence that ICF 10ms is
related to Glu/tCr (BF10=7.054). Further, there is substantial evidence
that the majority of TMS measures do not relate to MRS measures of
Glu/tCr, Gln/tCr or GABA/tCr. Most notably there is substantial
evidence for no relationship between SICI 3ms and SICI 3ms slope
and GABA/tCr (BF01=3.857 and 4.017 respectively). For full results of
Fig. 7. Spider web plots that illustrate Pearson correlation coeﬃcients between
individual values for each TMS measurement and Glutamine concentrations (Gln/tCr
ratios). The analyses revealed that there was a statistically signiﬁcant correlation between
Gln concentration and the median amplitude of each individual's MEP.
Fig. 8. Scatter plots that illustrate the association between TMS measures (Y axis) and MRS measures (X axis) for statistically signiﬁcant Pearson correlations. A. Illustrates the negative
correlation between MEP amplitude and Gln. B. Illustrates the positive correlation between 10 ms ICF and Glu. C. Illustrates the negative correlation between the plateau of the IO curve
for each individual and Glu concentration.
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the Bayesian Hypothesis Test please refer to Table 3.
Discussion
Imbalances in glutamatergic (excitatory) and GABA (inhibitory)
signalling within key brain networks are thought to underlie many
brain disorders, including: schizophrenia; depression; chronic pain;
and ‘hyperkinetic’ neurodevelopmental disorders such as TS (Clarke
et al., 2012; Ramamoorthi and Lin, 2011) and for this reason there is
considerable current interest in the use of MRS to measure in vivo
concentrations of brain molecules (e.g. GABA, glutamate, glutamine)
that can be correlated with brain function and dysfunction.
Importantly, while it is tempting to equate the GABA measured using
MRS (hereafter referred to as MRS-GABA) with neurotransmitter
function, and with physiological or behavioural inhibition (e.g.
Dharmadhikari et al. (2015); Haag et al. (2015)) it is important to
note that at any point in time only a fraction of MRS-GABA will be
neurotransmitter, and that increased MRS-GABA concentrations do
not necessarily mean that there is increased physiological or beha-
vioural inhibition (Rae, 2014). Furthermore, it is currently unclear
whether MRS-GABA represents the entire pool of GABA available for
measurement (i.e., metabolic, intracellular, and extracellular GABA), or
as some have argued, represents instead largely extracellular, extra-
synaptic, GABA that is unrelated to the synaptic transmission of GABA
(Rae, 2014; Stagg, 2014).
In the current study we compared directly, in the same individuals,
MRS-GABA (and other important neurometabolites such as glutamate
and glutamine) measured from a voxel located in the sensorimotor
cortex against TMS measures of cortical excitability and GABA-
mediated physiological inhibition measured from the hand area of
primary motor cortex. It is important to note that using these
techniques we obtained high-quality MRS data and replicated each of
the previously reported TMS eﬀects (i.e., TMS recruitment curves, 1 ms
SICI and 3 ms SICI curves, and 10 ms and 12 ms ICF eﬀects) that we
set out to examine in this study.
The main results of our study are summarised below.
1. Individual concentrations of MRS-GABA were unrelated to any TMS
measurements, including TMS measures of: general cortical excit-
ability (i.e., TMS recruitment curve slopes); GABA-mediated phy-
siological inhibition (i.e., 1 ms SICI and 3 ms SICI), and TMS
measures thought to be dependent upon the glutamatergic NMDA
receptor (i.e., 10 ms ICF and 12 ms ICF).
2. Individual levels of MRS-Glutamate (Glu) were signiﬁcantly nega-
tively correlated with the plateau of the IO curve; a measure which is
thought to reﬂect the balance of excitatory and inhibitory compo-
nents of the corticospinal volley (Devanne et al., 1997). The
relationship suggests that as levels of MRS-Glu increase the max-
imum MEP amplitude predicted by the model reduces. Multiple
regression analysis revealed Glu/tCR to be the only signiﬁcant
predictor of this measure and furthermore Bayesian hypothesis test
suggests very strong support in favour of the experimental hypoth-
esis.
3. MRS-Glu was also found to be marginally correlated with 10 ms but
not 12 ms ICF. The multiple regression analysis conﬁrmed that Glu/
tCR was a signiﬁcant predictor of 10 ms but not 12 ms ICF. Bayesian
hypothesis testing conﬁrmed that there is substantial evidence in
favour of the relationship.
4. There was some evidence of correlation between Glutamine (Gln)
concentrations and median amplitude of the MEP response to TMS
stimulation delivered at RMT. However, the Bayseian hypothesis
test revealed only anecdotal support in favour of the relationship.
This is possibly explained by the ﬁndings of the linear regression
model which reveal that median MEP amplitude was found to be
predicted by both the Gln/Glu and GABA/Glu ratios, but not
signiﬁcantly by Gln/tCR.
MRS-GABA and physiological inhibition
Our ﬁnding, that individual concentrations of MRS-GABA are
unrelated to GABA-mediated physiological inhibition, as measured by
3 ms SICI, replicates previous reports for 3 ms SICI (Tremblay et al.,
2013) and 2.5 ms SICI (Stagg et al., 2011). The physiological mechan-
isms that underpin both 2.5 ms and 3 ms SICI eﬀects are well
established and are thought to primarily involve post-synaptic inhibi-
tion mediated through GABA-A receptors (Ziemann et al., 2015).
Although SICI has also been found to be modulated by neurotrans-
mitters such as dopamine (Gilbert et al., 2006; Korchounov et al.,
2007; Ziemann, Bruns, et al., 1996), the contribution that such
neurotransmitters make to GABAergic neurotransmission is complex
(see (Hasselmo, 1995) and beyond the scope of this article (Hasselmo,
1995). As a result we suggest that the lack of correlation between 3ms
SICI and MRS-GABA observed in the current study and also previously
indicates that the primary source of MRS-GABA is unlikely to be that
associated with GABAergic synaptic transmission, but instead most
likely relates to concentrations of metabolic GABA and to levels of
ambient extracellular GABA that contribute to tonic GABAergic activity
and therefore to the GABAergic tone of a brain region (Rae, 2014;
Stagg, 2014).
In a previous study, Stagg and colleagues (Stagg et al., 2011)
reported a signiﬁcant correlation between MRS-GABA concentrations
and 1 ms SICI slopes. It is important to note that the underlying
physiological mechanisms for the 1 ms SICI eﬀect are thought to be
distinct from those associated with longer ISIs such as the 3 ms SICI
eﬀect (Cengiz et al., 2013; Fisher et al., 2002; Roshan et al., 2003),
however the exact mechanisms underlying 1 ms SICI are currently
unclear. Some have proposed that the eﬀects may relate to the
Table 2
Category values for BF10, table adapted from Wetzels and Wagenmakers (2012).
Bayes factor BF10 Interpretation
> 100 – ∞ Decisive evidence for H1
> 30 – < 100 Very strong evidence for H1
> 10 – < 30 Strong evidence for H1
> 3 – < 10 Substantial evidence for H1
> 1 – < 3 Anecdotal evidence for H1
1 No evidence
> 1/3 – < 1 Anecdotal evidence for H0
> 1/10 – < 1/3 Substantial evidence for H0
> 1/30 – < 1/10 Strong evidence for H0
> 1/100 – < 1/30 Very Strong evidence for H0
0 – < 1/100 Decisive evidence for H0
Table 3
Bayesian hypothesis te st for correlations. Data presented are each BF10 calculated to test
the relationship between MRS metabolites and TMS measures.
Glu/Cr Gln/Cr GABA/Cr
RMT 0.276† 0.280† 0.372
MedMEP 0.284† 1.670 0.427
S1 1mV 0.350 0.240† 0.262†
SICI 1ms 0.262† 0.239† 0.366
SICI 1ms Slope 0.244† 0.424 0.339
SICI 3ms 0.881 0.243† 0.259†
SICI 3ms Slope 0.266† 1.020 0.249†
ICF 10ms 7.054* 0.245 0.296†
ICF 12ms 0.253† 0.241† 0.239†
IO Maximal Slope 0.378 0.244† 0.346
IO Plateau 1119.593*** 0.246† 0.252†
*Substantial evidence for H1, **strong evidence for H1, ***decisive evidence for H1,
†substantial evidence for H0.
BF10 > 1 supports H1, BF10 < 1 supports H0, BF10=1 suggests no evidence.
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refractory periods of inter-neurons (Cengiz et al., 2013; Fisher et al.,
2002), whereas others have argued that synaptic processes may also
play a role (Roshan et al., 2003; Vucic et al., 2009).
Unfortunately, in the current study we do not replicate the ﬁnding
observed by Stagg et al. (2011) and we cannot readily account for this.
It is unlikely to be any lack of power in the current study as the sample
size used here was more that double that used previously (i.e., N=27
versus N=12). Similarly, it is also unlikely to be due to the eﬃcacy of
our TMS procedures as our 1ms SICI protocol was highly eﬀective in
producing eﬀective inhibition and we clearly observed a 1ms SICI
curve. The main diﬀerences between the two studies were the nature of
the MRS protocol used (i.e. SPECIAL versus STEAM) and the ﬁeld
strength of the MR scanners (i.e., 3 T versus 7 T). Obviously it is
diﬃcult to conclude anything from a null eﬀect, so at this point we take
the view that the previously observed relationship between 1 ms SICI
and MRS-GABA is not entirely reliable.
MRS-glutamate and glutamine and cortical excitability
TMS recruitment curves are thought to reﬂect cortical excitability
more generally and the strength of cortico-spinal projections (Chen,
2000). However, diﬀerent physiological processes may contribute to
the TMS recruitment curve across the diﬀerent stimulator intensities
used, and various neuromodulators and neurotransmitters, including
both GABA and Glu, may contribute to the eﬀects observed (Ziemann,
2013). Furthermore, diﬀerent aspects of the recruitment curve may
relate to diﬀerent mechanisms. It may be that measures of the slope of
the curve are distinct to measures of the plateau for example (Kouchtir-
Devanne et al., 2012).
Stagg et al. (2011) reported a signiﬁcant correlation between
cortical excitability, as indexed by the slope of the TMS recruitment
curve, and MRS-glutamate. We did not replicate this ﬁnding in the
current study and in fact found quite the opposite, at least at ﬁrst
appearance. We found the plateau of the IO curve to be negatively
correlated with Glu/tCr. We did not, however, ﬁnd a relationship
between IO curve and Glu/tCr. The most obvious diﬀerences between
both protocols as mentioned are the diﬀerences between the sequences
used to acquire MRS data, the scanner strength and the sample size.
Other possible explanations for the diﬀerences between these two
studies may be the subtle diﬀerences between the protocols used for
measuring TMS recruitment curves in each study. In the current study
we used a standard procedure; increasing the stimulator intensity in
10% increments proportional to an individual's resting motor thresh-
old. By contrast, Stagg et al. (2011) used a procedure in which the
percentage of the intensity needed to yield an MEP of 1mV was tracked
over time. This method ensures a similar degree of neuronal recruit-
ment across participants’ mid-slope, whereas the method that we used
ensures that this is the case at 100% of RMT. However, it is important
to note that despite these procedural diﬀerences, the IO curves
themselves appear to be similar. In particular, the mean amplitude
for MEPs in response to the highest stimulation was highly similar
across both experiments (i.e., approximately 3–3.5 mV) indicating that
the two methods were producing comparable eﬀects. For this reason we
feel that the diﬀerent results obtained in the two studies are unlikely to
have resulted from procedural diﬀerences in TMS stimulation.
At ﬁrst glance our ﬁnding appears to be somewhat unorthodox,
however, it highlights the importance that what we are measuring with
MRS (and TMS) is most probably not just “excitation” vs. “inhibition”.
Initially a high plateau may indicate more excitation, in which case, we
may expect more glutamate. This is simply not the case. Prior literature
describes that the maximum plateau of a recruitment curve does not
simply reﬂect the maximum output of the corticospinal system
(Devanne et al., 1997; Houdayer et al., 2008; Kouchtir-Devanne
et al., 2012). It may instead reﬂect the intrinsic balance of excitation
and inhibition at the PMC (Devanne et al., 1997). Few articles discuss
the cortical origins that lead to the plateau of a recruitment curve. One
experiment shows decreases in maximum plateau across diﬀerent
active muscle conditions is accompanied by reductions in SICI and
LICI but not in ICF (Kouchtir-Devanne et al., 2012) and have
speculated that this may relate to the functional coupling between
intracortical circuits within the PMC. At least one study has shown that
slope and plateau do not always change together and active high
frequency rTMS has been shown to reduce plateau and increase slope
(Houdayer et al., 2008), thus our ﬁndings may not be entirely
incompatible with Stagg's 2011 paper. Any conclusions from this
ﬁnding can only be speculation on our part, particularly since to our
knowledge there are no similar ﬁndings in the literature between IO
plateau and glutamate (or any other neurometabolite).
A signiﬁcant relationship was found between 10 ms but not 12 ms
ICF and MRS-glutamate. The lack of a signiﬁcant relationship with
12 ms is consistent with the previous ﬁndings by Stagg et al. (2011),
however, the relationship with 10 ms ICF is novel as this was not
measured in either of the previous TMS-MRS works (Stagg et al., 2011;
Tremblay et al., 2013). The mechanisms underlying ICF are not yet
fully understood, however, ICF is generally thought to test the
excitability of an excitatory neuronal motor network which is likely to
be modulated by both glutamatergic and GABAergic mechanisms
(Ziemann, 2013). ICF can be measured using ISIs of 7–20 ms
(Kujirai et al., 1993; Vucic et al., 2006) and although this is a relatively
large range of eﬀective ISIs, to our knowledge no clear distinction has
been drawn between these parameters (unlike SICI). Therefore,
although the results suggest support for the experimental hypothesis,
further study and replication of this eﬀect is warranted to draw strong
conclusions about this relationship.
Finally, we demonstrated that individual MEP amplitudes were
predicted by a linear combination of the ratios of glutamine/glutamate
and GABA/glutamate. Glutamate exists in several metabolic pools in
the brain and these pools serve as the source of glutamate for
neurotransmission. Also, there is a balanced cycling between glutamate
and glutamine that is essential for the normal operation of brain
functions and the levels of these neurometabolites are highly correlated
with one another in the healthy brain (Rae, 2014). Speciﬁcally,
Glutamate removed from the synaptic cleft is converted to glutamine
within astrocytes and astrocyte-derived glutamine is then used as a
precursor for the synthesis of glutamate or GABA within neurons. This
cycling of glutamate and glutamine between cell types in the brain is
highly dynamic and is thought to account for 80% of cerebral glucose
consumption (Ramadan et al., 2013). For this reason it is very likely
that TMS-induced changes in cortical excitability may be indexed by
subtle changes in the balance between glutamate and glutamine.
Overall the results of the current study reveal mixed support for the
previous ﬁndings reported thus far in the limited number of studies
that have directly compared the relationship between TMS measures of
cortical excitability and physiological inhibition (i.e., TMS recruitment
curves, ICF and SICI) and key neurometabolites (i.e., glutamate,
glutamine and GABA). Speciﬁcally, we ﬁnd that 3 ms SICI and MRS
measured GABA are uncorrelated, we interpret these ﬁndings as
consistent with the view that the GABA concentrations measured using
the MRS largely represent pools of extracellular GABA that are linked
to tonic rather than phasic inhibition and thus contribute to the
inhibitory tone of a brain area rather than GABAergic synaptic
transmission (Rae, 2014; Stagg, 2014).
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